These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36965898)

  • 1. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
    Ye Z; Jiang Y; Wu J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
    Wu X; Han Y; Liu F; Ruan L
    J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
    Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
    Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma.
    Lu Z; Wang C; Qu T; Feng Y
    Biomed Res Int; 2022; 2022():9957604. PubMed ID: 36199758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Necroptosis-Related Markers in Head and Neck Carcinoma by Bioinformatics.
    Zheng L; Li M; Gu R; Zhang H; Qi X; Dong H
    J Immunol Res; 2022; 2022():1993023. PubMed ID: 35785035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy.
    Xu X; Lu Z; Gross N; Li G; Zhang F; Lei D; Pan X
    J Cell Mol Med; 2019 Dec; 23(12):8280-8291. PubMed ID: 31578816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma.
    Guan J; Liu X; Wang K; Jia Y; Yang B
    Open Med (Wars); 2022; 17(1):1682-1698. PubMed ID: 36349193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma.
    Ma X; Yang B; Dong H; Lin H; Wang W
    J Oncol; 2022; 2022():9413562. PubMed ID: 36065304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.